"startup"

Current assumption is whoever builds the smartest model will control the future of AI. Recent events suggest a different possibility.

Eli Lilly's acquisition of AtaiBeckley for up to $3.8 billion, marks a pivotal moment for psychedelic medicine.

Most organizations aren't there yet. As agentic AI moves closer to production, that readiness gap is becoming harder to ignore.

Mira Murati’s $12B lab built its first model on Chinese foundations. Why nobody calls it theft, and what it means for OpenAI and US AI polic...

OpenAI and Anthropic have both confidentially filed for historic IPOs. Discover how their valuations, revenue growth, and corporate strategi...

The Bank of England is closely monitoring AI's growing risks to financial stability, fearing its impact could surpass previous tech waves.

In environments where software influences real clinical decisions, rigor is not optional. It is the condition that makes progress safe.

We need to urgently build the extreme heat technology stack. Leaders need to be equipped with the knowledge of the different technology solu...

The U.S. Department of Commerce lifted export controls on Anthropic's Claude Fable 5 and Mythos 5. What does it mean for enterprise AI, and...

OpenAI and Anthropic file for IPOs near $1 trillion as Washington clears Anthropic's Mythos 5, holds Fable 5 offline, and phases OpenAI's GP...

Computing ecosystems are changing dramatically. AI, quantum computing, exascale supercomputers, biological DNA, chemical and neuromorphic te...

U.S. and global tech stocks fell, led by AI giants amid valuation and bubble concerns.